Summary
Definition
History and exam
Key diagnostic factors
- heartburn
- regurgitation
- dysphagia
Other diagnostic factors
- asymptomatic (incidental finding)
- chest pain
- laryngitis
- cough, dyspnea or wheezing
- unintentional weight loss
Risk factors
- acid/bile reflux or GERD
- increased age
- white ethnicity
- male sex
- family history of Barrett esophagus or esophageal adenocarcinoma
- obesity
- smoking
Diagnostic tests
1st tests to order
- upper gastrointestinal endoscopy with biopsy
Tests to consider
- barium esophagogram
Emerging tests
- transnasal endoscopy
- capsule endoscopy
- wide-area transepithelial sampling with 3-dimensional analysis
- nonendoscopic cell collection device plus biomarker assay
Treatment algorithm
nondysplastic
low-grade dysplasia
high-grade dysplasia
Contributors
Authors
Sherif E. Elhanafi, MD
Associate Professor
Division of Gastroenterology
Texas Tech University Health Sciences Center
El Paso, TX
Disclosures
SEE declares that he has no competing interests.
Marc J. Zuckerman, MD
Professor of Medicine
Chief
Division of Gastroenterology
Texas Tech University Health Sciences Center
El Paso, TX
Disclosures
MJZ is on the speakers bureau for Phathom Pharmaceuticals and has received payments for giving dinner talks.
Acknowledgements
Dr Sherif E. Elhanafi and Dr Marc J. Zuckerman would like to gratefully acknowledge Dr Andres F. Carrion, Dr Ricardo Badillo, and Dr Vic Velanovich, previous contributors to this topic.
Disclosures
AFC and RB declare that they have no competing interests. VV is an author of a number of references cited in this topic.
Peer reviewers
D. Chamil Codipilly, MD
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, MN
Disclosures
DCC declares that he consults for Medtronic, a manufacturer of BarrX RFA system.
Peter McCulloch, MBChB, MA, MD, FRCS (Ed), FRCS (Glas)
Clinical Reader in Surgery
Nuffield Department of Surgery
University of Oxford
Oxford
UK
Disclosures
PM declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol. 2022 Apr 1;117(4):559-87.Full text Abstract
Weusten BLAM, Bisschops R, Dinis-Ribeiro M, et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2023 Dec;55(12):1124-46.Full text Abstract
National Institute for Health and Care Excellence. Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management. Feb 2023 [internet publication].Full text
Rubenstein JH, Sawas T, Wani S, et al. AGA clinical practice guideline on endoscopic eradication therapy of Barrett's esophagus and related neoplasia. Gastroenterology. 2024 Jun;166(6):1020-55.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Differentials
- Esophagitis
- GERD
- Esophageal squamous dysplasia/carcinoma
More DifferentialsGuidelines
- AGA clinical practice guideline on surveillance of Barrett's esophagus
- Endoscopic eradication therapy of Barrett’s esophagus and related neoplasia
More GuidelinesPatient information
Acid reflux, heartburn, and gastroesophageal reflux disease (GERD)
More Patient informationLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer




